Investments Core Scientific Shareholders Defy AMD similispharma@gmail.comAugust 9, 20260 InvestmentsBy Priya SharmaAugust 9, 20268 min read Key Takeaways Shareholders rejected a $9B sale to AMD, sparking debate. Investors bet…
Business News Jim Cramer Backs Nebius Stock similispharma@gmail.comJuly 9, 20260 Business NewsBy Rohan DesaiJuly 9, 20266 min read Key Takeaways Investors flock to Nebius Nebius dominates Canada's clean energy Innovations…